Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. - Wikidata - awgldk - TriplyDB

Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.

Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.

http://www.wikidata.org/entity/Q39481193

about

MicroRNA-143/-145 in Cardiovascular Diseases All's well that transcribes well: non-coding RNAs and post-stroke brain damage The emerging role of non-coding RNA in essential hypertension and blood pressure regulation.microRNAs in Essential Hypertension and Blood Pressure Regulation.micro-RNA screening and prediction model construction for diagnosis of salt-sensitive essential hypertension.Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia.Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function.Identifying microRNAs involved in aging of the lateral wall of the cochlear duct Differential Expression of MicroRNAs in Endarterectomy Specimens Taken from Patients with Asymptomatic and Symptomatic Carotid Plaques.Phenotypic switching of vascular smooth muscle cells in the 'normal region' of aorta from atherosclerosis patients is regulated by miR-145 An rs4705342 T>C polymorphism in the promoter of miR-143/145 is associated with a decreased risk of ischemic stroke.miRNA-145 inhibits VSMC proliferation by targeting CD40 Non-coding RNAs and hypertension-unveiling unexpected mechanisms of hypertension by the dark matter of the genome Hypertensive epigenetics: from DNA methylation to microRNAs.microRNAs in Cerebrovascular Disease.miRNAs and High-Density Lipoprotein metabolism.MiRNAs: potential diagnostic and therapeutic targets for cerebral ischaemia.microRNA profiling in atherosclerosis, diabetes, and migraine.The Epigenetic Machinery in Vascular Dysfunction and Hypertension.Myocyte Enhancer Factor 2A Regulates Hydrogen Peroxide-Induced Senescence of Vascular Smooth Muscle Cells Via microRNA-143.Placental trophoblast debris mediated feto-maternal signalling via small RNA delivery: implications for preeclampsia.Non-coding RNAs in cardiovascular disease: pathological relevance and emerging role as biomarkers and therapeutics.miRNA-145 is associated with spontaneous hypertension by targeting SLC7A1.MicroRNA profiling in migraine without aura: pilot study.Non-Coding RNA in the Pathogenesis, Progression and Treatment of Hypertension.MicroRNA-155 inhibits angiotensin II-induced vascular smooth muscle cell proliferation.Relationship of cardiovascular disease risk factors and noncoding RNAs with hypertension: a case-control study.

P2860

Q26801892-943A75A3-C584-429F-BFDF-FDEE2259FD9D Q27012757-1BBC267D-2212-4F24-B372-90FF1677F668 Q33359407-E4C5066E-4347-4CE3-B6C0-0B70C2A6A8AF Q33362101-77B6A293-6188-4EF2-B805-EB18DD7BE8E7 Q33627016-D336B966-7A33-43D5-9BFF-F152FAFF3E52 Q33816293-57205837-ED1B-449C-9395-7ABCE2F81AF0 Q34001116-9BCBB451-9D5A-494F-B643-C767ADF81AF2 Q34535461-B9C8CD53-40CF-433A-A260-DDC682BB5AC0 Q36133951-E1E90F21-8C74-47B1-9164-72E51D522EDC Q36942350-706883EC-1372-4942-A56F-F303523CC903 Q37314882-BD2FA5F1-61B8-489E-985B-47BA71EC415F Q37330365-95D6EE3D-6695-4B34-B3FF-E35B44208007 Q37741539-00EC02C2-0153-4C97-A9EF-827CD3C6E114 Q38335972-D3F57884-7EE7-4872-AEBB-2E1C892C3E6D Q38668253-85ED5C78-F056-4645-AF7A-E19C522EF83E Q38730644-0C324366-54FB-4C14-BA88-F4BE765461A6 Q38808277-892AE039-9237-4CC5-8B93-2C6BA3A748AB Q38827929-0E6B8CB3-C195-49FD-823B-8986FCA6CDEF Q39328207-A267467C-E7E6-4D6E-99F4-9D808D2EF150 Q42172356-B50D7F52-8088-4D0A-BC22-746FEA554ECF Q44182311-AF853CD6-DA51-4E5C-8602-AD49DAC05B07 Q46252008-FF5EC240-B405-4EF2-AE4C-3BC09119D5C0 Q49553269-6CA70C05-BB17-4465-9BD5-3C23E1797B9C Q50989062-266F3357-025F-452F-AB56-88978D39A9BE Q52347947-2903AED4-6747-461B-A7C8-8E5D12A36B76 Q53057396-21830F21-8CF4-4F26-83E1-923BFF75D9F1 Q54093236-D8A7D9AB-FF97-4609-91B0-F1F5CDEFE4E0

P2860

Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.

http://www.wikidata.org/entity/Q39481193

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.

@en

Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.

@nl

type

label

Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.

@en

Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.

@nl

prefLabel

Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.

@en

Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.

@nl

P1433

Q39481193-C553DA74-2B3B-413D-B24F-2E9F29563E00

P1476

Q39481193-635AF43D-565C-4B38-A765-DA965B83387C

P2093

Q39481193-0FF27D98-94CE-420D-A7CD-C91ACE87F4E5

Q39481193-1449675A-334F-48D3-AD8E-803213D678B1

Q39481193-329A32DA-ED78-46E7-AFD6-8292FCADD9E5

Q39481193-604F4918-C8B3-4896-BCEC-150CC2CBB9F0

Q39481193-6A657F3D-6DBB-44D7-81AA-D547622FE8BD

Q39481193-965C0CAC-4B91-4111-9856-14DB4E1E0174

Q39481193-A8FDDD0D-1AA7-439A-AAA3-25E3387F035D

Q39481193-ADB7C29A-3746-41F2-A0B5-F48C571539BC

Q39481193-AE9F8EA5-3B17-44F1-9028-C4B757A809D1

Q39481193-BD6CFDA7-D91E-4174-8B74-6E4AC4691AF2

P2860

Q39481193-007EE0B9-AF38-4E56-A57F-1E07ED77AF0F

Q39481193-1222BC39-3112-4406-85F4-635E3A212BAE

Q39481193-1C5E25AC-39BC-4444-8FE7-626B939F707E

Q39481193-4036904D-0B88-4A32-B9D4-7C491EC76EA7

Q39481193-454A31EF-6FB7-4625-BD50-55199E684F67

Q39481193-4A490F47-99EF-4FD7-A42C-6D2338FF01F9

Q39481193-5606ADB8-398D-4455-B1F8-AF9AC3694527

Q39481193-5AFBD52C-663C-4DD1-9D43-90427090D8EE

Q39481193-78BAA71B-9C7D-404F-9251-165817C09160

Q39481193-80F9D3D8-E5E4-4E4A-9DBD-99D28CC3E3C1

P304

Q39481193-A28F9E27-EBE0-461B-A41C-B0FD0C3C45A7

P31

Q39481193-C20566B3-F6A1-4213-BA7E-C00D88C0E2DC

P356

Q39481193-DAA6B578-41E0-4EF9-B623-431D26E5C534

P407

Q39481193-11709265-1E12-44BB-865C-A4D244BA3733

P433

Q39481193-815A0C88-26DC-4FE3-9CB5-373FBD09AC86

P478

Q39481193-DBEF439A-9580-4F6D-882E-6882F4E52EFC

P577

Q39481193-075597A1-CFFC-4804-AFD5-3B4C122EC0E6

P5875

Q39481193-E6F87FA1-05AE-4F50-A2D9-A6BBDC9CD999

P698

Q39481193-97D34E6C-5C97-4D9E-85FC-80D2B6F741EE

P921

Q39481193-A539C240-46AA-4C2F-B37A-7D19E32E287B

Q39481193-A572284A-4C9B-4656-9525-9C9EC8BDDDB9

Q39481193-F6DE7169-9C96-4723-B33D-629AB44FA87E

Q39481193-FB03F4C0-A640-47AD-B497-EC9D766A858E

P356

14728222.2013.745512

P1433

Expert Opinion on Therapeutic Targets

P1476

Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.

@en

P2093

Andrea Mezzetti

http://www.w3.org/2001/XMLSchema#string

Camilla Paganelli

http://www.w3.org/2001/XMLSchema#string

Claudia Mandolini

http://www.w3.org/2001/XMLSchema#string

Daniela Mastroiacovo

http://www.w3.org/2001/XMLSchema#string

Donato Santovito

http://www.w3.org/2001/XMLSchema#string

Francesco Cipollone

http://www.w3.org/2001/XMLSchema#string

Francesco Magnacca

http://www.w3.org/2001/XMLSchema#string

Giovambattista Desideri

http://www.w3.org/2001/XMLSchema#string

Marco Bucci

http://www.w3.org/2001/XMLSchema#string

Pamela Marcantonio

http://www.w3.org/2001/XMLSchema#string

P2860

The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease

MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury

MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation

Single-stranded antisense siRNAs guide target RNA cleavage in RNAi

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators

Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation

PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns

Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy.

Genes involved in systemic and arterial bed dependent atherosclerosis--Tampere Vascular study

Practical Aspects of microRNA Target Prediction.

P304

217-223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2013.745512

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235003051

http://www.w3.org/2001/XMLSchema#string

P698

23339529

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis